BMO Capital raises Ionis Pharmaceuticals price target to $61
BMO Capital raised its price target on Ionis Pharmaceuticals to $61.00 per share from $60.00 and maintained its Market Perform rating.
Ratings actions GMT) Ionis Pharmaceuticals Is Maintained at Market Perform by BMO CapitalRatings actions